Letter to the Editor: Lipoprotein Subparticles and Cardiovascular Risk in Liver Transplantation: More Details, More Significance
Pusen Wang, Lin Zhong – 26 September 2019
Crigler‐Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier
Kevin A. Strauss, Charles E. Ahlfors, Kyle Soltys, George V. Mazareigos, Millie Young, Lauren E. Bowser, Michael D. Fox, James E. Squires, Patrick McKiernan, Karlla W. Brigatti, Erik G. Puffenberger, Vincent J. Carson, Hendrik J. Vreman – 25 September 2019
Hyperpolarized Metabolic Imaging Detects Latent Hepatocellular Carcinoma Domains Surviving Locoregional Therapy
Nicholas R. Perkons, Ryan M. Kiefer, Michael C. Noji, Mehrdad Pourfathi, Daniel Ackerman, Sarmad Siddiqui, David Tischfield, Enri Profka, Omar Johnson, Stephen Pickup, Anthony Mancuso, Austin Pantel, Michelle R. Denburg, Gregory J. Nadolski, Stephen J. Hunt, Emma E. Furth, Stephen Kadlecek, Terence P. F. Gade – 25 September 2019
Patient Perspectives of High‐Quality Care on the Liver Transplant Waiting List: A Qualitative Study
Nicole T. Shen, Ashley Wu, Karen Farrell, Amanda Ivatorov, Enad Dawod, Michael Raver, Nicholas Russo, Laura Robbins, Monika Safford, Robert S. Brown – 25 September 2019 – The prevalence of advanced liver disease and listing for liver transplantation is increasing. Prior assessments of quality of care neither incorporate nor emphasize the patient perspective on quality of care, which may impact clinical outcomes.
Induction of Lysosome‐associated Protein Transmembrane 4 Beta via Sulfatase 2 Enhances Autophagic Flux in Liver Cancer Cells
Yeonjung Ha, Yong Fang, Paola A. Romecin Duran, Ezequiel J. Tolosa, Catherine D. Moser, Martin E. Fernandez‐Zapico, Lewis R. Roberts – 25 September 2019 – Autophagy has been shown to be a key cellular event controlling tumor growth in different neoplasms including hepatocellular carcinoma (HCC). Although this biological role of autophagy has been clearly established, the mechanism underlying its regulation remains elusive.
Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease
Veeral H. Ajmera, Amy Liu, Seema Singh, Georg Yachoa, Matthew Ramey, Meera Bhargava, Ava Zamani, Scarlett Lopez, Neeraj Mangla, Ricki Bettencourt, Emily Rizo, Mark Valasek, Cynthia Behling, Lisa Richards, Claude Sirlin, Rohit Loomba – 25 September 2019
Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort
Mazen Noureddin, Shira Zelber‐Sagi, Lynne R. Wilkens, Jacqueline Porcel, Carol J. Boushey, Loïc Le Marchand, Hugo R. Rosen, Veronica Wendy Setiawan – 25 September 2019
Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Myung Ji Goh, Dong Hyun Sinn, Seonwoo Kim, Sook Young Woo, Hyun Cho, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik – 25 September 2019
Is the Total Amount as Important as Localization and Type of Collagen in Liver Fibrosis Attributable to Steatohepatitis?
Morten A. Karsdal, Sönke Detlefsen, Samuel J. Daniels, Mette J. Nielsen, Aleksander Krag, Detlef Schuppan – 25 September 2019
LiverLearning®: 2019 Webinar: New Insights Into the Pathogenesis and Management of Cystic Fibrosis-Related Liver Disease
Our understanding of liver disease pathogenesis and manifestations in cystic fibrosis is evolving, as ongoing research and clinical experience expands. This webinar will provide updates on current understanding of CLFD pathogenesis, on strategies for diagnosis and monitoring, and on management of CFLD complications. We will utilize a live webinar format that will be recorded for on-demand viewing on Liver Learning ® .A. Jay Freeman Dr.